Most cited papers from Wichita Clinic

Wichita Clinic

What are the most cited papers from Wichita Clinic?

The most cited paper from Wichita Clinic is "Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer" (Edward H. Romond et al., 2005), with 5,398 citations. Next come "Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update" (1,132) and "Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial" (739).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 130 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer Edward H. Romond et al. · New England Journal of Medicine Open access	20 Oct 2005	5,398
2	Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update Charles L. Loprinzi, Christina Lacchetti, Jonathan Scott Bleeker et al. · Journal of Clinical Oncology Open access	14 Jul 2020	1,132
3	Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Charles L. Loprinzi, John W. Kugler, Jeff A Sloan et al. · The Lancet	Dec 2000	739
4	Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy Halle C. F. Moore et al. · New England Journal of Medicine Open access	4 Mar 2015	552
5	Testing for Unit Roots in Seasonal Time Series David Alan Dickey, David Paul Hasza, Wayne Arthur Fuller · Journal of the American Statistical Association	Jun 1984	547
6	Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124 Primo N. Lara, Ronald B. Natale, John Crowley et al. · Journal of Clinical Oncology Open access	7 Apr 2009	525
7	An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder Sheldon Preskorn, Bryan Baker, Sheela Kolluri et al. · Journal of Clinical Psychopharmacology	12 Nov 2008	520
8	Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update Toni K. Choueiri, Colin Hessel, Susan Halabi et al. · European Journal of Cancer Open access	20 Mar 2018	406
9	Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer Rita S. Mehta, William Eric Barlow, Kathy S. Albain et al. · New England Journal of Medicine Open access	Aug 2012	374
10	Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi et al. · Journal of Clinical Oncology	15 Jan 2002	364
11	Palliative Care for Patients With Cancer: ASCO Guideline Update Justin J. Sanders, Sarah Temin, Arunangshu Ghoshal et al. · Journal of Clinical Oncology Open access	15 May 2024	352
12	Arthroscopic Meniscal Repair Using an Exogenous Fibrin Clot Charles E. Henning, Mary A. Lynch, Kim M. Yearout et al. · Clinical Orthopaedics and Related Research	Mar 1990	349
13	MEDIA EQUATION: HOW PEOPLE TREAT COMPUTERS, TELEVISION, AND NEW MEDIA LIKE REAL PEOPLE AND PLACES Richard L. Soash · Collection Management	Sep 1999	348
14	Reliable Digit Span Ryan W. R. Schroeder, Philip Twumasi‐Ankrah, Lyle E. Baade et al. · Assessment	6 Dec 2011	333
15	Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study Kishan J. Pandya, Richard F. Raubertas, Patrick J. Flynn et al. · Annals of Internal Medicine	16 May 2000	312
16	A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031) John E. Godwin, Kenneth Joseph Kopecky, David R. Head et al. · Blood Open access	15 May 1998	311
17	Successful Catheter Ablation of Electrical Storm After Myocardial Infarction Dietmar Bänsch, Feifan Oyang, Matthias Antz et al. · Circulation Open access	9 Dec 2003	309
18	Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2 D. L. Barton, H. Liu, S. R. Dakhil et al. · JNCI Journal of the National Cancer Institute Open access	13 Jul 2013	298
19	A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma Aminah Jatoi, Neil M. Ellison, Patrick A. Burch et al. · Cancer	3 Mar 2003	289
20	College cheating: Ten years later George M. Diekhoff, Emily E. LaBeff, Robert Emerson Clark et al. · Research in Higher Education	Aug 1996	284
21	Vortex breakdown on slender sharp-edged wings William H. Wentz, DAVID L. KOHLMAN · Journal of Aircraft	Mar 1971	271
22	A New Autosomal Dominant Disorder of Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, and Acne: PAPA Syndrome Noralane M. Lindor, Todd M. Arsenault, Herman Solomon et al. · Mayo Clinic Proceedings	Jul 1997	265
23	A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA Debra L. Barton, Edward J. Wos, Rui Qin et al. · Supportive Care in Cancer Open access	24 May 2010	255
24	Traumatic rupture of the aorta: Still a lethal injury R. Stephen Smith, Frederic C. Chang · The American Journal of Surgery	Dec 1986	239
25	Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma Erica Hlavin Bell et al. · Journal of Clinical Oncology Open access	24 Jul 2020	233
26	Determinants and Consequences of Social Trust* Michael R. Welch, Roberto Rivera, Brian P. Conway et al. · Sociological Inquiry	11 Oct 2005	228
27	Diet, Fluid, or Supplements for Secondary Prevention of Nephrolithiasis: A Systematic Review and Meta-Analysis of Randomized Trials Howard A Fink, Joseph W. Akornor, Pranav Sandilya Garimella et al. · European Urology ReviewOpen access	14 Mar 2009	223
28	A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9) Aminah Jatoi, Howard L. Ritter, Amylou Constance Dueck et al. · Lung Cancer Open access	9 Aug 2009	221
29	Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA Debra L. Barton, Gamini S. Soori, Brent A. Bauer et al. · Supportive Care in Cancer Open access	5 May 2009	216
30	Knee Joint Surface Changes Mary A. Lynch, Charles E. Henning, Karl R. Glick · Clinical Orthopaedics and Related Research	1983	207
31	Low‐dose, single‐agent temsirolimus for relapsed mantle cell lymphoma Stephen Maxted Ansell, David James Inwards, Kendrith M. Rowland et al. · Cancer Open access	9 Jun 2008	205
32	Does primary intraocular lens implantation prevent “aphakic” glaucoma in children? Sanjay Asrani, Sharon F. Freedman, Vic Hasselblad et al. · Journal of American Association for Pediatric Ophthalmology and Strabismus	Feb 2000	203
33	Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232) Jeffrey A. Zonder, John Crowley, Mohamad A. Hussein et al. · Blood Open access	28 Sep 2010	194
34	Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study Jeanne E. Anderson, Kenneth Joseph Kopecky, Cheryl L. Willman et al. · Blood	14 Nov 2002	192
35	Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074 Joon H. Uhm, Karla V. Ballman, Wenting Wu et al. · International Journal of Radiation OncologyBiologyPhysics Open access	26 May 2010	192
36	Characteristics of biliary tract complications during laparoscopic cholecystectomy: A multi-institutional study Michael S. Woods, L. William Traverso, Richard A. Kozarek et al. · The American Journal of Surgery	1994	191
37	Misoprostol Dosage in the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Gastric and Duodenal Ulcers: A Comparison of Three Regimens Jeffrey B. Raskin, Richard H. White, Joseph E. Jackson et al. · Annals of Internal Medicine	Sep 1995	190
38	The Effect of Obesity on Outcomes among Injured Patients Matthew C. Byrnes, Mark D. McDaniel, Michael B Moore et al. · The Journal of Trauma: Injury, Infection, and Critical Care	Feb 2005	177
39	Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131 Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016 Oliver W. Press, Joseph M. Unger, Lisa M. Rimsza et al. · Journal of Clinical Oncology Open access	11 Dec 2012	175
40	Tetracycline to prevent epidermal growth factor receptor inhibitor‐induced skin rashes Aminah Jatoi, Kendrith M. Rowland, Jeff A. Sloan et al. · Cancer Open access	9 Jun 2008	175
41	Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial Amanda R. Moraska, Amit Sood, Shaker R. Dakhil et al. · Journal of Clinical Oncology Open access	13 Jul 2010	173
42	The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial Lisa A. Kottschade, Jeff A. Sloan, Miroslaw A. Mazurczak et al. · Supportive Care in Cancer Open access	9 Oct 2010	173
43	Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4 Robert Clell Miller, David J. Schwartz, Jeff A. Sloan et al. · International Journal of Radiation OncologyBiologyPhysics Open access	27 Aug 2010	169
44	Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study David Spiegel, Gary R. Morrow, Catherine C. Classen et al. · Psycho-Oncology	Nov 1999	165
45	Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial Kostandinos Sideras, Paul Schaefer, Scott H. Okuno et al. · Mayo Clinic Proceedings	Jun 2006	163
46	Treatment of cerebrospinal fluid shunt infections: a decision analysis RACHEL T. SCHREFFLER, ANDREW J. SCHREFFLER, Robert R. Wittler · The Pediatric Infectious Disease Journal	Jul 2002	154
47	Information-Seeking Styles Among Cancer Patients Before and After Treatment by Demographics and Use of Information Sources Christie R. Eheman, Zahava Berkowitz, Judith Lee Smith et al. · Journal of Health Communication Open access	31 Jul 2009	153
48	One Hundred Three Consecutive Patients With Anorectal Malformations and Their Associated Anomalies Sechin Cho, Shawn P. Moore, Tony Fangman · Archives of Pediatrics and Adolescent Medicine	May 2001	151
49	Factors influencing a woman’s choice to undergo breast-conserving surgery versus modified radical mastectomy R. Joseph Nold, Robert L. Beamer, Stephen D. Helmer et al. · The American Journal of Surgery	Dec 2000	146
50	Cancer patients' expectations of experiencing treatment‐related side effects Maarten Hofman, Gary R. Morrow, Joseph A. Roscoe et al. · Cancer Open access	12 Jul 2004	144

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.